University Medical Center
Welcome,         Profile    Billing    Logout  
 4 Trials 
15 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ahsan, Chowdhury
ACTIV-4, NCT04505774 / 2020-004285-19: Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE

Completed
4
3591
Europe, US, RoW
theraputic heparin, unfractionated heparin, Enoxaparin, Dalteparin, Tinzaparin, Heparin, prophylactic heparin, enoxaparin, dalteparin, Fondparinux, P2Y12, Ticagrelor, Prasugrel, Clopidogrel, Crizanlizumab Injection, SGLT2 inhibitor, dapagliflozin, empagliflozin, canagliflozin, ertugliflozin
Matthew Neal MD, National Heart, Lung, and Blood Institute (NHLBI)
Covid19
08/23
01/24
AIM-POWER, NCT04191330: Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

Active, not recruiting
N/A
122
US
BiovitalsHF
Biofourmis Inc.
Heart Failure
06/24
08/24
NCT05206422: DORAYA-HF Early Feasibility Study

Recruiting
N/A
30
US
Doraya Catheter
Revamp Medical Inc.
Acute Decompensated Heart Failure
10/25
12/25
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Recruiting
N/A
1400
Europe, US, RoW
Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation
Medtronic Vascular
Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
11/26
11/29
Robinson, Jennifer
SIL02, NCT03142568: Safety of Sildenafil in Premature Infants

Recruiting
2
120
Canada, US
Sildenafil, Revatio, Placebo, sugar water
University of North Carolina, Chapel Hill, Duke University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), The Emmes Company, LLC
Bronchopulmonary Dysplasia
02/25
04/25
CBD, NCT04831294: Effects of Cannabidiol () on the Brain

Active, not recruiting
N/A
15
US
Cannabidiol, CBD, Placebo
Auburn University, Folium Biosciences, FutureCeuticals
CBD, Fear, Inhibition
05/22
12/23
NCT05206422: DORAYA-HF Early Feasibility Study

Recruiting
N/A
30
US
Doraya Catheter
Revamp Medical Inc.
Acute Decompensated Heart Failure
10/25
12/25
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Recruiting
N/A
1400
Europe, US, RoW
Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation
Medtronic Vascular
Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
11/26
11/29
NCT05438979: Joint Health Study

Recruiting
N/A
300
US
Placebo, Calcium Fructoborate, CFB
Auburn University
Effect of Drug
06/24
12/24
NCT06540118: Food is Medicine for Patients with Heart Failure

Recruiting
N/A
60
US
15 Medically Tailored Meals (MTM) per week, 14 Medically Tailored Meals (MTM) per week
University of California, San Diego, Stanford University
Heart Failure, Heart Failure，Congestive, Heart Diseases
06/25
06/25
Bardakcioglu, Ovunc
NCT06309368: Ostomy Primary Closure With 0.1% Betaine/0.1% Polyhexanide Wound Irrigation Compared to Pursestring Closure

Recruiting
4
84
US
Primary Ostomy Closure with 0.1% Betaine/0.1% Polyhexanide Wound Irrigation, Prontosan, Pursestring Closure
University of Nevada, Las Vegas
Surgical Site Infection, Wound Surgical, Colorectal Disorders
12/24
12/25
NCT04651764: Transanal Resection of Rectal Lesions With the ColubrisMX ELS System

Terminated
N/A
26
US
ColubrisMX Endoluminal Surgical (ELS) System
ColubrisMX
Rectal Adenoma, Rectal Polyp, Rectal Lesion
06/21
06/21
Asad, Shadaba
RESOLUTION, NCT04417257: Study of LAU-7b for the Treatment of COVID-19 Disease in Adults

Completed
2/3
125
Canada, US
LAU-7b, fenretinide, Placebo oral capsule
Laurent Pharmaceuticals Inc.
COVID-19 Disease
02/24
05/24
Haber, Jordana
RISE-C, NCT05989841: Mitigating PTSD-CUD After Sexual Assault

Recruiting
N/A
100
US
RISE Guide, Relaxation Control
University of Nevada, Las Vegas, University of North Carolina, Chapel Hill
Posttraumatic Stress Disorder, Cannabis Use Disorder
02/26
02/27
Cheng, Abigail W
NCT06309368: Ostomy Primary Closure With 0.1% Betaine/0.1% Polyhexanide Wound Irrigation Compared to Pursestring Closure

Recruiting
4
84
US
Primary Ostomy Closure with 0.1% Betaine/0.1% Polyhexanide Wound Irrigation, Prontosan, Pursestring Closure
University of Nevada, Las Vegas
Surgical Site Infection, Wound Surgical, Colorectal Disorders
12/24
12/25

Download Options